Physician profile
Christopher Tyree
NPI 1245610062
$21,257.53
in general payments reported to CMS, 2019-2025
31 companies · $472 in 2025
The $472 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,562 · 2020: $162 · 2021: $1,611 · 2022: $4,644 · 2023: $3,309 · 2024: $2,497 · 2025: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,319 · Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,318.94 |
| Food and Beverage | $1,959.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,749.21 | 2019-2024 | |
| Peerless Surgical INC. | $5,469.10 | 2019-2024 | |
| Medical Device Business Services, INC. | $2,319.12 | 2019-2023 | |
| Paragon 28, INC. | $2,263.77 | 2019-2024 | Portfolio, Precision Mis Bunion |
| Dne LLC | $742.90 | 2019 | |
| Medline Industries Lp | $574.37 | 2019 | |
| Treace Medical Concepts, INC. | $432.20 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $375.77 | 2021-2024 | Nuzyra |
| Celularity INC. | $267.00 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $134.20 | 2020 | |
| Depuy Synthes Sales INC. | $125.53 | 2019-2023 | Motoband |
| Kowa Pharmaceuticals America, INC. | $115.66 | 2023 | Seglentis |
| Progenacare Global, LLC | $94.20 | 2023 | |
| Boston Scientific Corporation | $89.58 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Smith+Nephew, INC. | $75.24 | 2021-2024 | Stravix, Grafix Pl |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $69.85 | 2022-2025 | Puraply, Puraply Wound Matrix |
| Medtronic Vascular, INC. | $64.80 | 2019 | |
| Stryker Corporation | $61.71 | 2022-2023 | Ortholoc 2 Lapifuse |
| Amgen INC. | $32.62 | 2024 | Krystexxa |
| Abbvie INC. | $26.99 | 2021-2024 | |
| Bioventus LLC | $20.90 | 2023 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $20.45 | 2023 | Qutenza |
| Convatec INC. | $19.53 | 2025 | |
| Osiris Therapeutics INC. | $18.92 | 2019 | |
| Triad Life Sciences INC. | $16.40 | 2022 | |
| Kci USA, INC. | $15.64 | 2020 | |
| Horizon Therapeutics Plc | $14.05 | 2021 | |
| Sebela Pharmaceuticals INC. | $13.99 | 2019 | |
| Ermi LLC | $12.20 | 2020 | |
| Misonix INC | $11.55 | 2021 | |
| Next Science LLC | $10.08 | 2023 | Blastx, Xperience, Surgx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Tyree listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.